Firstly appreciate all your post, as long term holder (2012), hoping this our turning point. I asked this yesterday on another post but no one replied, In an analysis you did on the valuation recently and in particular the Covid-19 ARDS potential what would you say the Cost of ramping up production for this in particular treatment would be based on your revenue numbers for this treatment.
I would find your estimate helpful.
Firstly appreciate all your post, as long term holder (2012),...
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.51 |
Change
0.020(1.34%) |
Mkt cap ! $1.724B | |||
| Open | High | Low | Value | Volume |
| $1.57 | $1.58 | $1.41 | $18.15M | 12.09M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3418 | $1.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.51 | 24361 | 5 |
View Market Depth
| Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |